当前位置：首页 > 文献互助 > 互助详情

期刊论文A first-in-human phase 1/2 dose-escalation study of MAK683 (EED inhibitor) in patients with advanced malignancies复制

用户7nEFK6amBq5Y 1天前 91 已关闭

文献链接:复制

其他信息:

互助时间线

楼主用户7nEFK6amBq5Y关闭了求助

Colesevelam hydrochloride: synthesis and testing of a novel polymer gel pharmaceutical 5小时前

Adrenoceptors: Receptors, Ligands and Their Clinical Uses, Molecular Pharmacology and Assays 6小时前

Lipid Nanoparticles for mRNA Delivery in Cancer Immunotherapy 7小时前

Quantitative Pharmacology Methods for Bispecific T Cell Engagers 7小时前

TRPA1 siRNA-Loaded Nanoformulation Ameliorates Chemotherapy-Induced Peripheral Neuropathy 8小时前

Targeting QPCTL: An Emerging Therapeutic Opportunity 9小时前

40 million deaths by 2050: toll of drug-resistant infections to rise by 70% 9小时前

A Deep-Learning-Aided Drug Screening Based on Visualization of a Hidden Layer as Chemical Space 10小时前

Novel potential avenues for the therapy of Tourette syndrome: Cannabinoid- and steroid-based interventions 10小时前

分光光度法测定发芽和未发芽的蚕豆（Vicia faba L.）和鹰嘴豆（Cicer aritinum L.）中的 L-多巴 13小时前